{"id":"https://openalex.org/W2031278751","doi":"https://doi.org/10.1196/annals.1432.042","title":"Serotonin (5\u2010HT) Transporter Ligands Affect Plasma 5\u2010HT in Rats","display_name":"Serotonin (5\u2010HT) Transporter Ligands Affect Plasma 5\u2010HT in Rats","publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W2031278751","doi":"https://doi.org/10.1196/annals.1432.042","mag":"2031278751","pmid":"https://pubmed.ncbi.nlm.nih.gov/18991872"},"language":"en","primary_location":{"id":"doi:10.1196/annals.1432.042","doi":"https://doi.org/10.1196/annals.1432.042","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1432.042","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103446078","display_name":"Richard B. Rothman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard B. Rothman","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA. rrothman@mail.nih.gov","Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA. rrothman@mail.nih.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087490307","display_name":"Dorota \u017b\u00f3\u0142kowska","orcid":"https://orcid.org/0000-0003-1988-0119","observed_orcids":["https://orcid.org/0000-0003-1988-0119"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["PL","US"],"is_corresponding":false,"raw_author_name":"Dorota Zolkowska","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA","Department of Hygiene, Medical University of Lublin, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Department of Hygiene, Medical University of Lublin, Poland","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004773599","display_name":"Michael H. Baumann","orcid":"https://orcid.org/0000-0001-7758-1470","observed_orcids":["https://orcid.org/0000-0001-7758-1470"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H. Baumann","raw_affiliation_strings":["Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, DHHS, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5103446078"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":1.1549,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.73424709,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"1139","issue":"1","first_page":"268","last_page":"284"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.0142000000923872,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.8009999990463257},{"id":"https://openalex.org/keywords/fenfluramine","display_name":"fenfluramine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8970000147819519},{"id":"https://openalex.org/keywords/plasma-serotonin","display_name":"plasma serotonin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/idiopathic-pulmonary-arterial-hypertension","display_name":"idiopathic pulmonary arterial hypertension","score":0.8849999904632568},{"id":"https://openalex.org/keywords/valvular-heart-disease","display_name":"valvular heart disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.6650000214576721},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2779638493","wikidata":"https://www.wikidata.org/wiki/Q418928","display_name":"Fenfluramine","level":4,"score":0.9886542558670044},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.671596348285675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5605761408805847},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.547297477722168},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.5186764001846313},{"id":"https://openalex.org/C2781083316","wikidata":"https://www.wikidata.org/wiki/Q3025599","display_name":"Dexfenfluramine","level":5,"score":0.5124762654304504},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.5092934370040894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5035161375999451},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4479135274887085},{"id":"https://openalex.org/C2777369949","wikidata":"https://www.wikidata.org/wiki/Q567709","display_name":"Anorectic","level":3,"score":0.4413710832595825},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4389669895172119},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.42385318875312805},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38552558422088623},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3437938690185547},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09542974829673767},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.09114435315132141}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005277","descriptor_name":"Fenfluramine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005277","descriptor_name":"Fenfluramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1196/annals.1432.042","doi":"https://doi.org/10.1196/annals.1432.042","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1432.042","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:18991872","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18991872","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":90,"referenced_works":["https://openalex.org/W43634972","https://openalex.org/W82237388","https://openalex.org/W142700705","https://openalex.org/W1557315818","https://openalex.org/W1965258805","https://openalex.org/W1973372223","https://openalex.org/W1973660081","https://openalex.org/W1974650692","https://openalex.org/W1985682725","https://openalex.org/W1986398321","https://openalex.org/W1986647496","https://openalex.org/W1987660432","https://openalex.org/W1988836653","https://openalex.org/W1990733410","https://openalex.org/W1991617358","https://openalex.org/W1993653750","https://openalex.org/W1996588278","https://openalex.org/W1997136041","https://openalex.org/W1997740633","https://openalex.org/W1998906057","https://openalex.org/W2006127303","https://openalex.org/W2007151271","https://openalex.org/W2007312125","https://openalex.org/W2011985298","https://openalex.org/W2013125542","https://openalex.org/W2015390870","https://openalex.org/W2016634116","https://openalex.org/W2022099155","https://openalex.org/W2024779449","https://openalex.org/W2027775751","https://openalex.org/W2028096169","https://openalex.org/W2033705393","https://openalex.org/W2035427061","https://openalex.org/W2038926594","https://openalex.org/W2039765797","https://openalex.org/W2040336481","https://openalex.org/W2045573797","https://openalex.org/W2047296947","https://openalex.org/W2049459518","https://openalex.org/W2052304909","https://openalex.org/W2053030710","https://openalex.org/W2054549715","https://openalex.org/W2060796735","https://openalex.org/W2062550341","https://openalex.org/W2062736973","https://openalex.org/W2071280486","https://openalex.org/W2072400382","https://openalex.org/W2074406974","https://openalex.org/W2080412419","https://openalex.org/W2080778917","https://openalex.org/W2083497351","https://openalex.org/W2089424993","https://openalex.org/W2090706622","https://openalex.org/W2092465977","https://openalex.org/W2101632061","https://openalex.org/W2106319447","https://openalex.org/W2106484959","https://openalex.org/W2108545817","https://openalex.org/W2108805152","https://openalex.org/W2111156355","https://openalex.org/W2113404778","https://openalex.org/W2116085129","https://openalex.org/W2124057487","https://openalex.org/W2124549431","https://openalex.org/W2133037699","https://openalex.org/W2135092212","https://openalex.org/W2137426923","https://openalex.org/W2138117456","https://openalex.org/W2145500736","https://openalex.org/W2146774202","https://openalex.org/W2150237820","https://openalex.org/W2152907844","https://openalex.org/W2159309468","https://openalex.org/W2160218325","https://openalex.org/W2161932072","https://openalex.org/W2165515041","https://openalex.org/W2166049758","https://openalex.org/W2166140637","https://openalex.org/W2170554697","https://openalex.org/W2271897004","https://openalex.org/W2326556388","https://openalex.org/W2329065056","https://openalex.org/W2337229884","https://openalex.org/W2413272757","https://openalex.org/W2467224864","https://openalex.org/W2473762969","https://openalex.org/W2550590520","https://openalex.org/W2988610037","https://openalex.org/W3023130045","https://openalex.org/W4235085549"],"related_works":["https://openalex.org/W2089424993","https://openalex.org/W7100604416","https://openalex.org/W2135092212","https://openalex.org/W2138117456","https://openalex.org/W4231003649","https://openalex.org/W1988836653","https://openalex.org/W2106319447","https://openalex.org/W30321165","https://openalex.org/W2086879053","https://openalex.org/W2002984799"],"abstract_inverted_index":{"Dual":[0],"dopamine":[1],"(DA)/serotonin":[2],"(5-HT)-releasing":[3],"agents":[4],"are":[5,21,225],"promising":[6],"candidate":[7],"medications":[8],"for":[9,46,115,251],"stimulant":[10],"addiction":[11],"and":[12,31,49,66,69,90,93,112,131,176,181,210,238],"other":[13,70,159],"disorders.":[14],"However,":[15],"certain":[16],"5-HT":[17,75,138,150,221],"transporter":[18],"(SERT)":[19],"substrates":[20,42,161],"associated":[22,253],"with":[23,254],"development":[24],"of":[25,64,122,156,196,203],"idiopathic":[26],"pulmonary":[27],"arterial":[28],"hypertension":[29],"(IPAH)":[30],"valvular":[32],"heart":[33],"disease":[34],"(VHD).":[35],"According":[36],"to":[37,165,206,222,231],"the":[38,44,62,119,201,227,248],"\"5-HT":[39],"hypothesis,\"":[40],"SERT":[41,71,160],"increase":[43],"risk":[45,250],"developing":[47],"IPAH":[48,252],"VHD":[50],"by":[51],"increasing":[52],"plasma":[53,74,149,170,186,220,244,262],"5-HT.":[54,171,216,263],"To":[55],"test":[56,87,104],"this":[57],"hypothesis":[58],"directly,":[59],"we":[60],"determined":[61],"effects":[63,242],"acute":[65,80,204],"chronic":[67,100,189],"fenfluramine,":[68],"ligands,":[72],"on":[73,243],"in":[76,145,169,184,261],"male":[77],"rats.":[78],"For":[79,99],"treatments,":[81,101],"rats":[82,124],"received":[83,125],"i.v.":[84,126],"vehicle":[85,102],"or":[86,103,158,198],"drug":[88,105],"(0.3":[89],"1.0":[91],"mg/kg),":[92,130],"serial":[94,132],"blood":[95,133],"samples":[96,134],"were":[97,135],"withdrawn.":[98,136],"was":[106,139,151],"infused":[107],"via":[108],"osmotic":[109],"minipump":[110],"(3":[111],"10":[113,177],"mg/kg/d)":[114],"2":[116],"weeks.":[117],"On":[118],"last":[120],"day":[121],"infusion,":[123],"fenfluramine":[127,157,173,197,205,218,237,255],"challenge":[128],"(1":[129],"Plasma":[137],"measured":[140],"using":[141],"ex":[142],"vivo":[143],"microdialysis":[144],"whole-blood":[146,215],"samples.":[147],"Baseline":[148],"<1.0":[152],"nM.":[153],"Acute":[154,217],"injection":[155],"caused":[162],"large":[163],"(up":[164],"24-fold)":[166],"dose-dependent":[167],"increases":[168,183,219],"Chronic":[172,194,236],"at":[174],"3":[175],"mg/kg/d":[178],"produced":[179],"1.7-":[180],"3.5-fold":[182],"baseline":[185],"5-HT,":[187,209,245],"while":[188],"fluoxetine":[190,199,239],"had":[191],"no":[192],"effect.":[193],"infusions":[195],"diminished":[200],"ability":[202],"elevate":[207],"dialysate":[208],"both":[211],"drugs":[212],"markedly":[213],"reduced":[214],"concentrations":[223],"that":[224,247],"below":[226],"micromolar":[228],"levels":[229],"necessary":[230],"produce":[232],"adverse":[233],"cardiovascular":[234],"effects.":[235],"have":[240],"minimal":[241],"suggesting":[246],"increased":[249],"does":[256],"not":[257],"depend":[258],"upon":[259],"elevations":[260]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}